Achilles Therapeutics Plc Stock Market Value
| ACHL Stock | USD 1.06 0.01 0.93% |
| Symbol | Achilles |
Achilles Therapeutics PLC Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achilles Therapeutics. If investors know Achilles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achilles Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Return On Assets (0.27) | Return On Equity (0.44) |
The market value of Achilles Therapeutics PLC is measured differently than its book value, which is the value of Achilles that is recorded on the company's balance sheet. Investors also form their own opinion of Achilles Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Achilles Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achilles Therapeutics' market value can be influenced by many factors that don't directly affect Achilles Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achilles Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Achilles Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achilles Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Achilles Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Achilles Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Achilles Therapeutics.
| 12/01/2023 |
| 11/25/2024 |
If you would invest 0.00 in Achilles Therapeutics on December 1, 2023 and sell it all today you would earn a total of 0.00 from holding Achilles Therapeutics PLC or generate 0.0% return on investment in Achilles Therapeutics over 360 days. Achilles Therapeutics is related to or competes with Assembly Biosciences, Spero Therapeutics, Instil Bio, Nuvation Bio, CytomX Therapeutics, and NextCure. Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapi... More
Achilles Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Achilles Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Achilles Therapeutics PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.54 | |||
| Information Ratio | 0.1107 | |||
| Maximum Drawdown | 38.16 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 3.06 |
Achilles Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Achilles Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Achilles Therapeutics' standard deviation. In reality, there are many statistical measures that can use Achilles Therapeutics historical prices to predict the future Achilles Therapeutics' volatility.| Risk Adjusted Performance | 0.1153 | |||
| Jensen Alpha | 0.4567 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.1978 | |||
| Treynor Ratio | 0.4507 |
Achilles Therapeutics PLC Backtested Returns
Achilles Therapeutics appears to be very risky, given 3 months investment horizon. Achilles Therapeutics PLC secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of standard deviation over the last 3 months. By analyzing Achilles Therapeutics' technical indicators, you can evaluate if the expected return of 0.63% is justified by implied risk. Please makes use of Achilles Therapeutics' risk adjusted performance of 0.1153, and Mean Deviation of 2.03 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Achilles Therapeutics holds a performance score of 10. The firm shows a Beta (market volatility) of 1.38, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Achilles Therapeutics will likely underperform. Please check Achilles Therapeutics' downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Achilles Therapeutics' price patterns will revert.
Auto-correlation | -0.6 |
Good reverse predictability
Achilles Therapeutics PLC has good reverse predictability. Overlapping area represents the amount of predictability between Achilles Therapeutics time series from 1st of December 2023 to 29th of May 2024 and 29th of May 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Achilles Therapeutics PLC price movement. The serial correlation of -0.6 indicates that roughly 60.0% of current Achilles Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.6 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Achilles Therapeutics PLC lagged returns against current returns
Autocorrelation, which is Achilles Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Achilles Therapeutics' stock expected returns. We can calculate the autocorrelation of Achilles Therapeutics returns to help us make a trade decision. For example, suppose you find that Achilles Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Achilles Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Achilles Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Achilles Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Achilles Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Achilles Therapeutics Lagged Returns
When evaluating Achilles Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Achilles Therapeutics stock have on its future price. Achilles Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Achilles Therapeutics autocorrelation shows the relationship between Achilles Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Achilles Therapeutics PLC.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Achilles Therapeutics Correlation, Achilles Therapeutics Volatility and Achilles Therapeutics Alpha and Beta module to complement your research on Achilles Therapeutics. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Achilles Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.